General Information
Drug ID
DR00415
Drug Name
Fenofibrate
Synonyms
AZU, Fenofibrat; AbZ Brand of Procetofen; Abbott Brand of Procetofen; Aliud Brand of Procetofen; Ankebin; Antara; Antara (TN); Antara (micronized); Antara Micronized Procetofen; Anto Brand of Procetofen; Apo Feno Micro; Apo Fenofibrate; Apo-Feno-Micro; Apo-Fenofibrate; Apotex Brand of Procetofen; Azupharma Brand of Procetofen; Betapharm Brand of Procetofen; Bouchara Brand of Procetofen; CIP-Fenofibrate; Controlip; Ct Arzneimittel Brand of Procetofen; Ct-Arzneimittel Brand of Procetofen; Debat, Fenofibrate; Durafenat; Elasterate; Elasterin; F 6020; FENOFIBRATE (MICRONIZED); FNF; Fenobeta; Fenobrate; Fenocor-67 (TN); Fenofanton; Fenofibrat AL; Fenofibrat AZU; Fenofibrat AbZ; Fenofibrat FPh; Fenofibrat Heumann; Fenofibrat Hexal; Fenofibrat Stada; Fenofibrat ratiopharm; Fenofibrat von ct; Fenofibrat-ratiopharm; Fenofibrate (JAN/INN); Fenofibrate Debat; Fenofibrate IDD-P; Fenofibrate MSD; Fenofibrate [INN:BAN]; Fenofibrato; Fenofibrato [INN-Spanish]; Fenofibratum; Fenofibratum [INN-Latin]; Fenogal; Fenogal (TN); Fenoglide; Fenomax; Fenotard; Finofibrate; Fournier Brand of Procetofen; Fulcro; GNR Pharma Brand of Procetofen; GNR-Pharma Brand of Procetofen; GRS-027; Gate Brand of Procetofen; Gen Fenofibrate; Gen-Fenofibrate; Genpharm Brand of Procetofen; Heumann Brand of Procetofen; Heumann, Fenofibrat; Hexal Brand of Procetofen; Hexal, Fenofibrat; Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate; Isopropyl 2-(p-(p-chlorobenzoyl)phenoxy)-2-methylpropionate; Isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate; Knoll Brand of Procetofen; LCP-Feno; LCP-FenoChol; LF 178; LF-178; LF178; Lichtenstein Brand of Procetofen; Lipanthyl; Lipanthyl (TN); Lipantil; Lipantil (TN); Liparison; Lipidex; Lipidil; Lipidil (TN); Lipidil Micro; Lipidil Supra; Lipidil Ter; Lipidil-Ter; Lipifen; Lipirex; Lipoclar; Lipofen; Lipofen (TN); Lipofene; Liposit; Lipsin; Lofibra; Lofibra (TN); Luxacor; MTW Brand of Procetofen; MTW Fenofibrat; MTW-Fenofibrat; Merck dura Brand of Procetofen; Micronized Procetofen, Antara; Nolipax; Novartis Brand of Procetofen; Novo Fenofibrate; Novo-Fenofibrate; Novopharm Brand of Procetofen; Nu Fenofibrate; Nu Pharm Brand of Procetofen; Nu-Fenofibrate; Nu-Pharm Brand of Procetofen; PMS Fenofibrate Micro;Pharmascience Brand of Procetofen; PMS-Fenofibrate Micro; Pharmavit; Phenofibrate; Procetofen; Procetofen Reliant Brand; Procetofen, Antara Micronized; Procetofene; Proctofene; Protolipan; Q Pharm Brand of Procetofen; Q-Pharm Brand of Procetofen; Ratiopharm Brand of Procetofen; Reliant Brand of Procetofen; Schering Plough Brand of Procetofen; Schering-Plough Brand of Procetofen; Secalip; Sedufen; Stada, Fenofibrat; Stadapharm Brand of Procetofen; Supralip; TRICOR (MICRONIZED); Tricor; Tricor (TN); Triglide; Triglide (TN); Trilipix (TN); United Drug Brand of Procetofen
Drug Type
Small molecular drug
Therapeutic Class
Antilipemic Agents
Structure
3D MOL 2D MOL
Formula
C20H21ClO4
Canonical SMILES
CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
InChI
InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3
InChIKey
YMTINGFKWWXKFG-UHFFFAOYSA-N
CAS Number
CAS 49562-28-9
Pharmaceutical Properties Molecular Weight 360.8 Topological Polar Surface Area 52.6
Heavy Atom Count 25 Rotatable Bond Count 7
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4
XLogP
5.2
PubChem CID
3339
PubChem SID
10321317 , 10852041 , 11111181 , 11111182 , 11335732 , 11360971 , 11364144 , 11366706 , 11369268 , 11372481 , 11373845 , 11377430 , 11461943 , 11466303 , 11467423 , 11485116 , 11486105 , 11489206 , 11491246 , 11492228 , 11495064 , 11528711 , 11533532 , 143271 , 14901407 , 17405049 , 22395205 , 24278015 , 26612151 , 26680406 , 26746914 , 26746915 , 26751450 , 29222474 , 3718278 , 46507371 , 47291103 , 47291104 , 47365158 , 47515293 , 47662254 , 47736448 , 47810726 , 5309234 , 7847631 , 7979221 , 8149697 , 8152122 , 855565 , 9788
ChEBI ID
ChEBI:5001
TTD Drug ID
D07XGR

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.